Type
Veen. Aspects of temporary specific anergy to tuberculin in Vietnamese refugees. Public Health. [Groningen]: Groningen University; 1992. p. 119 p.
Type
Guo, Ao. Phage in the diagnosis and treatment of tuberculosis. Frontiers in Bioscience. 2012;17:2691-2697.
Type
World Health Organization. Global tuberculosis report 2018. [Internet]. Geneva: World Health Organization; 2018. Report No.: WHO/CDS/TB/2018.20. Available from: http://www.who.int/tb/publications/global_report/en/
Type
Ogbomo. Information needs of rural health professionals: A case study of the tuberculosis and leprosy referral center (tb/l), Eku, Delta State. International Journal of Human Sciences [Internet]. 2012;9(2):188–205. Available from: http://insanbilimleri.com/ojs/index.php/uib/article/view/2112
Type
Mitchison D. Prevention of drug resistance by combined drug treatment of tuberculosis. Handbook of experimental pharmacology. 2012;(211):87-98.
Type
Zachariah, Harries, Srinath, Ram, Viney, Singogo, et al. Language in tuberculosis services: can we change to patient-centred terminology and stop the paradigm of blaming the patients?. The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease. 2012;16(6):714-7.
Type
Ditiu L, Kumar B. Tuberculosis care: why the words we use matter. The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease. 2012;16(6):711.
Type
Bhattacharya, Ranadive, Kale, Bhattacharya. Antibody-Based Enzyme-Linked Immunosorbent Assay for Determination of Immune Complexes in Clinical Tuberculosis. The American Review of respiratory diseases. 1986;134(2):205-9.
Type
National Tuberculosis and Leprosy Programme. Ministry of Health manual of the National Tuberculosis and Leprosy Programme [Internet]. 2nd ed.nd ed. Ministry of Health, Republica of Uganda; 2010. Available from: http://www.who.int/hiv/pub/guidelines/uganda_tb.pdf
Type
Teles R, Graeber T, Krutzik S, Montoya D, Schenk M, Lee D, et al. Type I interferon suppresses type II interferon-triggered human anti-mycobacterial responses. Science (New York, N.Y.). 2013;339(6126):1448-53.